The white paper discusses the critical role of specialty pharmacies in supporting the commercialization of rare and gene therapies. It highlights the importance of choosing a strategic partner with expertise in clinical excellence, patient access, storage, distribution, and data insights. Specialty pharmacies like Accredo offer tailored services that go beyond traditional logistics, ensuring that patients receive necessary therapies promptly and safely. The document also emphasizes the importance of continuous evaluation, collaboration with stakeholders, and leveraging data to optimize therapy outcomes. The paper concludes by underscoring the growing complexity of rare disease care and the necessity of a trusted specialty pharmacy partner.

Join for free to read